Neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer

Journal of Surgical Research

Volumn 163, Issue 1, 2010, Pages 52-57

  Kennedy, Carlie R ^a   Gao, Feng ^a   Margenthaler, Julie A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adjuvant chemotherapy; breast cancer; neoadjuvant chemotherapy; triple negative

Indexed keywords

DOXORUBICIN; TAXANE DERIVATIVE;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; TRIPLE NEGATIVE BREAST CANCER; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; MISSOURI; NEOADJUVANT THERAPY; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77955920483     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.04.015     Document Type: Article

References (29)

1. E. Rakha, M. El-Sayed, and A. Green Prognostic markers in triple-negative breast cancer Cancer 109 2007 25
2. N.U. Lin, A. Vanderplas, and M.E. Hughes Clinicopathological features and sites of recurrence according to breast cancer subtype in the National Comprehensive Cancer Network (NCCN) J Clin Oncol 27 2009 (Abstr 543)
3. C.M. Perou, T. Sorlie, and M.B. Eisen Molecular portraits of human breast tumours Nature 406 2000 747
4. R. Conforti, F.C. Bidard, and S. Michiels Discrepancy between triple-negative phenotype and basal-like tumor: An immunohistochemical analysis based on 150 "triple negative" breast cancers Breast Cancer Res Treat 106 2007 S135
5. T.O. Nielsen, F.D. Hsu, and K. Jensen Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 2004 5367
6. J.M. Dolle, J.R. Daling, and E. White Risk factors for triple-negative breast cancer in women under the age of 45 years Cancer Epidemiol Biomarkers Prev 18 2009 1157
7. R. Millikan, B. Newman, and C.-K. Tse Epidemiology of basal-like breast cancer Breast Cancer Res Treat 109 2008 123
8. L.A. Carey, C.M. Perou, and C.A. Livasy Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2006 2492
9. T. Sorlie, R. Tibshirani, and J. Parker Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 2003 8418
10. D. Abd El-Rehim, B. Graham, and S. Pinder High-throughput protein expression analysis using tissue microarray technology of a large well-characterized series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses Int J Cancer 116 2005 340
11. L.A. Carey, E.C. Dees, and L. Sawyer The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes Clin Cancer Res 13 2007 2329
12. J. Hugh, J. Hanson, and M.C.U. Cheang Breast cancer subtypes and response to docetaxel in node-positive breast cancer: Use of an immunohistochemical definition in the BCIRG 001 trial J Clin Oncol 27 2009 1168
13. M.J. Burnell, E.M. O'Connor, and J.W. Chapman Triple-negative receptor status and prognosis in the NCIC CTG MA. 21 adjuvant breast cancer trial J Clin Oncol (Meeting Abstracts) 26 2008 (Abstr 550)
14. J. Jacquemier, F. Penault-Llorca, and H. Mnif Identification of a basal-like subtype and comparative effect of epirubicin-based chemotherapy and sequential epirubicin followed by docetaxel chemotherapy in the PACS 01 breast cancer trial: 33 markers studied on tissue-microarrays (TMA) J Clin Oncol (Meeting Abstracts) 24 2006 (Abstr 509)
15. M. Tischkowitz, J.-S. Brunet, and L. Begin Use of immunohistochemical markers can refine prognosis in triple negative breast cancer BMC Cancer 7 2007 134
16. R. Dent, M. Trudeau, and K.I. Pritchard Triple-negative breast cancer: Clinical features and patterns of recurrence Clin Cancer Res 13 2007 4429
17. L. Fulford, D. Easton, and J. Reis-Filho Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast Histopathology 49 2006 22
18. L. Harris, G. Broadwater, and N. Lin Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: Results from CALGB 9342 Breast Cancer Res 8 2006 R66
19. C. Liedtke, C. Mazouni, and K.R. Hess Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer J Clin Oncol 26 2008 1275
20. N.U. Lin, E. Claus, and J. Sohl Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer Cancer 113 2008 2638
21. F. Heitz, P. Harter, and A. Traut Cerebral metastases (CM) in breast cancer (BC) with focus on triple-negative tumors J Clin Oncol (Meeting Abstracts) 26 2008 (Abstr 1010)
22. S. Dawood, K. Broglio, and F.J. Esteva Survival among women with triple receptor-negative breast cancer and brain metastases Ann Oncol 20 2009 621
23. R. Rouzier, C.M. Perou, and W.F. Symmans Breast cancer molecular subtypes respond differently to preoperative chemotherapy Clin Cancer Res 11 2005 5678
24. American Joint Committee on Cancer S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, AJCC Cancer Staging Manual 2002 Springer New York 221
25. J.P. Ferriere, I. Assier, and H. Cure Primary chemotherapy in breast cancer: Correlation between tumor response and patient outcome Am J Clin Oncol 21 1998 117
26. M.R. Machiavelli, A.O. Romero, and J.E. Perez Prognostic significance of pathological response of the primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma Cancer J Sci Am 4 1998 125
27. N. Wolmark, J. Wang, and E. Mamounas Preoperative chemotherapy in patients with operable breast cancer: Nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18 J Natl Cancer Inst Monogr 2001 96
28. P. Rastogi, S.J. Anderson, and H.D. Bear Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 J Clin Oncol 26 2008 778
29. M. Colleoni, M. Bonetti, and A.S. Coates Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors J Clin Oncol 18 2000 584